Ji Hea Sung

EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release

Koung Jin Suh, Ji Hea Sung, Jin Won Kim et al. · Oncotarget · 2017 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines

Sung-Ung Moon, Jin Won Kim, Ji Hea Sung et al. · Cancer Research and Treatment · 2014 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

EGF Induced RET Inhibitor Resistance in<i>CCDC6-RET</i>Lung Cancer Cells

Hyun Chang, Ji Hea Sung, Sung Ung Moon et al. · Yonsei Medical Journal · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer

Kui‐Jin Kim, Ji‐Won Kim, Ji Hea Sung et al. · Scientific Reports · 2020 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells

Sung Ung Moon, Mi Hyun Kang, Ji Hea Sung et al. · Oncology Reports · 2014 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +10